CENTRAL NERVOUS SYSTEM TUMOR
Clinical trials for CENTRAL NERVOUS SYSTEM TUMOR explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM TUMOR trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with resistant tumors: drug combo enters safety trial
Disease control OngoingThis early-stage study tests a combination of two drugs, avutometinib and defactinib, in children and young adults (ages 3 to 30) with advanced or recurrent solid tumors that have specific genetic changes. The main goal is to find the safest dose with the fewest side effects. The…
Matched conditions: CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with tough cancers: neratinib trial underway
Disease control OngoingThis study tests the safety and effectiveness of neratinib, a targeted cancer drug, in children whose solid tumors, brain tumors, lymphoma, or leukemia have come back or not responded to standard treatments. The drug is taken by mouth daily in 28-day cycles. The main goal is to f…
Matched conditions: CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC